Ir(III) Complexes for Photodynamic Therapy

  • Author: Chemistry – A European Journal
  • Published Date: 27 November 2018
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Ir(III) Complexes for Photodynamic Therapy

Related Societies

Photodynamic therapy (PDT) is a chemotherapeutic protocol against cancer. It acts selectively in cancerous tissues after local activation with light. Upon light excitation, a photosensitizer (PS) initiates a photochemical reaction that produces biologically active species at cytotoxic levels.

Gustavo Espino, Begoña Garcí­a, Universidad de Burgos, Spain, and colleagues have prepared neutral biscyclometalated Ir(III) complexes (pictured) as potential PS agents against colon cancer. The complexes have the general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O or 2‐(benzothiazolyl)phenolate‐N,O, and the C^N ligands are 2‐(phenyl)pyridinate derivatives. The compounds are phosphorescent, generate singlet oxygen (1O2) photocatalytically, and accumulate in cancer cells.

The team identified the complex of formula [Ir(dfppy)2(L)] (dfppy = 2‐(4,6‐difluorophenyl)pyridinate, L = 2‐(benzimidazolyl)phenolate‐N,O) as a potential agent for PDT. This complex combines excellent photophysical properties, internalization in cancer cells, and a good ability for 1O2 production. It shows an eightfold rise in cytotoxic activity upon blue-light irradiation versus in the dark. The team found that the photophysical and electrochemical properties of the described complexes depend preeminently on the N^O ligand. More studies are necessary to better understand the strong effects on the anticancer properties derived from the subtle structural change in the O^N ligand.


Article Views: 1809

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH